Katie Stiles

Title: The Innovative Contributions of Katie Stiles

Introduction

Katie Stiles is a prominent inventor based in the Bronx, NY (US). She has made significant contributions to the field of gene therapy, particularly in addressing eosinophilic disorders and alpha 1-antitrypsin deficiency. With a total of 3 patents to her name, her work is paving the way for new therapeutic approaches.

Latest Patents

Katie's latest patents include groundbreaking innovations. One of her notable inventions is a gene therapy for eosinophilic disorders, which provides compositions and methods for treating eosinophilia in mammals. This therapy utilizes a viral gene therapy vector, and a single dose of the vector has been shown to reduce increased eosinophil counts effectively. Another significant patent is for an oxidation-resistant AAT gene therapy, which offers a treatment for alpha 1-antitrypsin deficiency. This therapy comprises a plasmid or viral vector that codes for an elastase- or cathepsin G-inhibiting, oxidation-resistant human AAT with specific substitutions.

Career Highlights

Katie Stiles is affiliated with Cornell University, where she continues her research and development in gene therapy. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

Katie collaborates with esteemed colleagues, including Ronald G Crystal and Odelya E Pagovich. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Katie Stiles is a remarkable inventor whose work in gene therapy is making a significant impact in the medical field. Her innovative patents and collaborations reflect her dedication to advancing healthcare solutions.